Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,915.00
Bid: 4,915.00
Ask: 4,916.00
Change: 62.00 (1.28%)
Spread: 1.00 (0.02%)
Open: 4,883.00
High: 4,940.00
Low: 4,853.00
Prev. Close: 4,853.00
CRDA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

20 Apr 2018 11:14

RNS Number : 6351L
Croda International PLC
20 April 2018
 

The following amendment has been made to the Directorate Change announcement released on 20 April 2018 at 07:00 under RNS No 5187L.

 

Name amended from Robert to Roberto in the first paragraph.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

 

20 April 2018

 

 

Croda International Plc

 

 

Appointment of Non-Executive Directors - Board succession planning

 

 

The Board of Croda International Plc is pleased to announce the appointment of Roberto Cirillo and Jacqui Ferguson as non-executive directors. Roberto will join the Board with effect from 26 April 2018 and Jacqui will join with effect from 1 September 2018.

 

These appointments strengthen the Board's skills and experience in the areas of strategy, operations, international/emerging markets and digitalisation.

 

Roberto has worked in a number of international roles over the last 20 years, most recently as CEO of Optegra, the international eye healthcare company. Before that he was at Sodexo, where he played a critical role in the company's transformation and growth, working in a variety of roles, including in strategy and later as Group COO and as Country CEO of their French business. Prior to that Roberto worked as a consultant at Mckinsey & Company across many different areas and countries.

 

Jacqui has almost 30 years' experience in international roles in the technology sector. She held many senior operating roles at Hewlett Packard, including SVP & General Manager of HP's Enterprise Services Division in Europe whose business was to deliver digital and technology enabled transformations for enterprises. She was also Chief of Staff at Hewlett Packard working with the Chairman and CEO focused on a new company strategy and transformation. Prior to Hewlett Packard Jacqui worked for Electronic Data Systems, acquired by HP in 2008, and KPMG. Jacqui is currently a non-executive director of Wood Plc.

 

On joining the Board, both Jacqui and Roberto will also be appointed to the Audit, Nomination and Remuneration Committees. 

 

Anita Frew, Chairman of Croda International Plc, said,

 

"Both appointments will be of enormous benefit to the Croda Board, supporting our strategic plans to connect more dynamically to customers through the use of technology and helping customers transition to more sustainable ingredients. Roberto brings with him a wealth of international experience in operations and strategy and Jacqui a deep knowledge of digital as well as experience in operating in emerging markets. The appointments will also bring greater diversity to the Board in terms of gender, tenure, nationality and experience. We are delighted to welcome them both to the Croda Board.

 

"As previously announced, Nigel Turner will be retiring from the Board on 26 April 2018, at which time Alan Ferguson will take on the role of Senior Independent Director.

 

"Steve Williams will have served on the Board for nine years in 2019. In preparation for his retirement next year, Helena Ganczakowski will take over as Chairman of the Remuneration Committee with effect from 26 April 2018. This will give Helena a good period as Chairman to prepare for the Committee's review of the Company's remuneration policy at the end of the year. Helena has been a member of the Remuneration Committee since 1 February 2014.

 

"All these changes to the Board are consistent with the Board's approach to succession planning."

 

There are no further matters to be disclosed under LR9.6.13R of the Listing Rules of the UK Listing Authority.

 

 

 

 

Enquiries:

 

Shareholders: Conleth Campbell, VP Investor Relations +44 1405 860 551

 

Press: Charlie Armistead, Teneo Blue Rubicon +44 203 603 5220

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAMMGZDGGZGRZM
Date   Source Headline
28th Mar 20249:17 amRNSDirector/PDMR Shareholding
26th Mar 20244:19 pmRNSDirector/PDMR Shareholding
26th Mar 20244:10 pmRNSDirector/PDMR Shareholding
26th Mar 20244:09 pmRNSDirector/PDMR Shareholding
26th Mar 20244:09 pmRNSDirector/PDMR Shareholding
26th Mar 20244:07 pmRNSDirector/PDMR Shareholding
26th Mar 20244:06 pmRNSDirector/PDMR Shareholding
26th Mar 20244:04 pmRNSDirector/PDMR Shareholding
15th Mar 20249:32 amRNSAnnual Financial Report
12th Mar 20242:49 pmRNSDirector/PDMR Shareholding
7th Mar 20243:03 pmRNSDirector/PDMR Shareholding
27th Feb 20247:00 amRNSResults for the year ended 31 December 2023
13th Feb 20243:35 pmRNSDirector/PDMR Shareholding
9th Feb 20243:28 pmRNSHolding(s) in Company
18th Jan 20241:33 pmRNSHolding(s) in Company
11th Jan 20243:17 pmRNSDirector/PDMR Shareholding
18th Dec 20237:00 amRNSDirectorate Change
12th Dec 20233:08 pmRNSDirector/PDMR Shareholding
11th Dec 202311:39 amRNSDirector Declaration
29th Nov 20234:54 pmRNSHolding(s) in Company
28th Nov 20239:35 amRNSDirector/PDMR Shareholding
24th Nov 202311:33 amRNSHolding(s) in Company
14th Nov 20239:40 amRNSDirector/PDMR Shareholding
19th Oct 202311:19 amRNSHolding(s) in Company
19th Oct 202310:34 amRNSDirector/PDMR Shareholding
12th Oct 202311:46 amRNSDirector/PDMR Shareholding
9th Oct 20237:00 amRNSThird Quarter Trading Update
6th Oct 20234:12 pmRNSDirector/PDMR Shareholding
5th Oct 20238:53 amRNSHolding(s) in Company
3rd Oct 20234:03 pmRNSDirector/PDMR Shareholding
27th Sep 20235:17 pmRNSDirector/PDMR Shareholding
26th Sep 202311:38 amRNSDirector/PDMR Shareholding
22nd Sep 20237:00 amRNSDirectorate Change
15th Sep 202311:51 amRNSDirector/PDMR Shareholding
12th Sep 20234:01 pmRNSDirector/PDMR Shareholding
12th Sep 20238:56 amRNSDirector/PDMR Shareholding
11th Aug 20232:26 pmRNSDirector/PDMR Shareholding
1st Aug 20237:13 amRNSDirector Declaration
25th Jul 20237:00 amRNSResults for the six months ended 30 June 2023
11th Jul 20232:57 pmRNSDirector/PDMR Shareholding
4th Jul 20238:02 amRNSCroda completes acquisition of Solus Biotech
26th Jun 202310:46 amRNSHolding(s) in Company
13th Jun 20233:55 pmRNSDirector/PDMR Shareholding
12th Jun 20232:06 pmRNSDirector/PDMR Shareholding
9th Jun 20237:00 amRNSTrading update
31st May 20232:47 pmRNSDirector/PDMR Shareholding
26th May 20233:51 pmRNSDirector/PDMR Shareholding
11th May 20234:05 pmRNSDirector/PDMR Shareholding
3rd May 20233:08 pmRNSDirector/PDMR Shareholding
3rd May 20233:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.